Curriculum Vitae

AEBi Chairman of the Board
  • Leading the balance: funding, IP approach, investor relations, R&D targets & business development activity.
Dan Aridor Holdings Ltd. Owner
  • Raising funds from the start up level and onward. Among the more notable transactions was provision of assistance to York Capital in the purchase of Psagot Ofek hedge funds (a transaction in the scope of over a quarter of a billion dollars). Involved in cutting-edge technology assessment and associated business plans.
Aridor & Shor Managing Partner
  • Developed marketing business plans and technical strategies for applied technologies for small to medium size companies.
Admati Research International Director
  • Managed all aspects of the day to day operations.
Mitzuv, Ltd. Senior Consultant
  • Designed multifaceted strategic plans.
SBD Strategic Business Development Consultant
  • Analyzed business performance of private & public companies and government controlled industries.
Israel Ministry of Defense Buyer
  • Procured military electronics equipment for the Israeli Air Force. Negotiated and closed multi-million dollar defense contracts.

Columbia Business School NY, USA

M.B.A. Student
  • Major in Finance.

Bar-Ilan University, Israel

  • Economics & Business Management Major One year concentration in Mathematics and Computer Sciences.

There is no clinical tryout at the moment of MuTaTo in Israel or outside of Israel.

Contact us at office@aebi-bio.com

Contact Us

    Our team are research scientists (Ph.D.) and are not attending Dr.

    We are working now for the 20th year entering our 21th year of R&D effort (in June 2022).

    We don’t have a Clinique and we can not advise nor refer to any specific case.

    We initially intend to target: lung, colon, head & neck cancers.

    The treatment, in any case, has to be individually adapted to the patient.

    We are a small team and have an influx of e-mail.

    We try to answer at least initial emails but can not promise it.

    This website may contain certain statements, estimations, projections, assessments and other information with respect to the anticipated future performance of the Company and/or its market and involve risks and uncertainties. Actual results or future business decisions of the Company may differ materially from any expectations, projections or predictions made or implicated in statements made in this website. While the Company believes that the information contained herein is accurate, it expressly disclaims any and all liability for representations or warranties, expressed or implied, contained in, or for omissions from, this website or any other communication transmitted or made available herein. Any prospective website user acknowledges his/her responsibility to perform a due diligence review prior to consummating a transaction with the Company. Included in this website are certain declarations by the Company with respect to its anticipated future performance. These declarations are based on estimates and assumptions by the Company that are subject to economic and competitive uncertainties beyond the control of the Company. The Company does not provide representation or warranty with regard to the declarations and there can be no assurance that the future results will be realized or that actual results will not be significantly different from those projected. The Company is not obligated to update or revise any future declarations. The Company and its respective affiliates, directors, officers, employees, consultants and representatives expressly disclaim any and all liability relating to or resulting from the utilization of any information contented in this website. The Company does not have any obligation to provide with access to additional information.